Clinical Trial Update: Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Topotecan plus apatinib versus Topotecan alone as second-line therapy for small-cell lung cancer is being studied. The status of the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Topotecan (Hycamtin) (Topotecan)

Snippet

Sponsor: First Hospitals affiliated to the China PLA General Hospital | Conditions: Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN